Raphael Pharmaceutical Inc.
RAPH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $19 | $230 | $288 | $153 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2 | $7 | $38 | $92 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $0 | $5 | $177 |
| Total Curr. Assets | $25 | $237 | $331 | $422 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $2 | $2 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $27 | $239 | $333 | $422 |
| Liabilities | – | – | – | – |
| Payables | $125 | $69 | $72 | $107 |
| Short-Term Debt | $41 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $603 | $63 | $155 | $187 |
| Total Curr. Liab. | $769 | $132 | $227 | $294 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $769 | $132 | $227 | $294 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $187 | $185 | $157 | $130 |
| Retained Earnings | -$8,889 | -$7,370 | -$6,026 | -$2,667 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $7,960 | $7,292 | $5,975 | $2,665 |
| Total Equity | -$742 | $107 | $106 | $128 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $27 | $239 | $333 | $422 |
| Net Debt | $22 | -$230 | -$288 | -$153 |